BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-523@pharmaconomics
DTSTAMP:20260707T015436Z
DTSTART;VALUE=DATE:20261231
DTEND;VALUE=DATE:20270101
SUMMARY:ATAI Phase 2 — BPL-003 (estimated date)
DESCRIPTION:Phase 2 trial results for BPL-003 in treatment-resistant depression are due ~ Dec 31\, 2026. A clean hit validates the program\; a miss can gap the stock down hard.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/2081043/000114036126020708/ef20072731_ex99-1.htm\n\nTrack it: https://pharmaconomics.com/e/523
URL:https://pharmaconomics.com/e/523
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:ATAI catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR